Avadel Pharmaceuticals (AVDL) Other Operating Expenses (2016 - 2021)
Historic Other Operating Expenses for Avadel Pharmaceuticals (AVDL) over the last 7 years, with Q1 2021 value amounting to -$53000.0.
- Avadel Pharmaceuticals' Other Operating Expenses fell 10188.01% to -$53000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$53000.0, marking a year-over-year decrease of 10010.91%. This contributed to the annual value of -$53000.0 for FY2021, which is 10011.58% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Other Operating Expenses stood at -$53000.0 for Q1 2021, which was down 10188.01% from $45.8 million recorded in Q2 2020.
- Avadel Pharmaceuticals' 5-year Other Operating Expenses high stood at $72.8 million for Q4 2018, and its period low was -$53000.0 during Q1 2021.
- Over the past 5 years, Avadel Pharmaceuticals' median Other Operating Expenses value was $5.3 million (recorded in 2017), while the average stood at $13.9 million.
- Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 125122.59% in 2018, then tumbled by 10188.01% in 2021.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Other Operating Expenses stood at $5.4 million in 2017, then surged by 1251.23% to $72.8 million in 2018, then crashed by 93.55% to $4.7 million in 2019, then skyrocketed by 874.65% to $45.8 million in 2020, then tumbled by 100.12% to -$53000.0 in 2021.
- Its Other Operating Expenses was -$53000.0 in Q1 2021, compared to $45.8 million in Q2 2020 and $2.8 million in Q1 2020.